相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
Mohammad S. Siddiqui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis
Samuel J. Daniels et al.
HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease
Raj Vuppalanchi et al.
HEPATOLOGY (2018)
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study
Ramy Younes et al.
LIVER INTERNATIONAL (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety
Elizabeth P. Mills et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2018)
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
W-K. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
Mazen Noureddin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2018)
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M. Younossi et al.
HEPATOLOGY (2018)
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar-Gomez et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease
Luis C. Bertot et al.
LIVER INTERNATIONAL (2018)
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration
Y. A. Patel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
Stuart McPherson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey
R. J. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
I. Doycheva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study
J. Cui et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
R. Kwok et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Gender and Menopause Impact Severity of Fibrosis Among Patients With Nonalcoholic Steatohepatitis
Ju Dong Yang et al.
HEPATOLOGY (2014)
A population-based study on the prevalence of NASH using scores validated against liver histology
Jenni Hyysalo et al.
JOURNAL OF HEPATOLOGY (2014)
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2013)
Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic
Joern M. Schattenberg et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
Einar Björnsson et al.
JOURNAL OF HEPATOLOGY (2011)
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease
R. Pais et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2011)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)